Yashoda Hospitals > Medicine FAQS > Ticagrelor

Ticagrelor: Frequently Asked Questions Answered

What is Ticagrelor?

Ticagrelor is a generic medication that prevents and inhibits platelet aggregation. The aggregation of platelets may cause unwanted blood clots in the bloodstream. Therefore, there is a restriction in the smooth blood flow. However, this may lead to fatal consequences. Doctors prescribe this medication when a patient with a history of angina or heart attack is highly likely to develop abnormal blood clotting issues. Notably, one stops its usage before undergoing any surgical procedure.

What can Ticagrelor benefit you?

Ticagrelor can inhibit platelet aggregation, and thus, this drug helps prevent heart attack and stroke with a similar past medical history. Moreover, after some heart surgeries like stent placement procedures, doctors prescribe this medicine as management therapy. It is to avoid the risk of abnormal post-surgical blood clotting. It helps to ensure smooth blood flow, especially in patients at high risk of developing unwanted fatal blood clots.

Book Appointment

Online Video Consultation

Book Doctor Appointment

Health Packages

What are the adverse effects Ticagrelor can lead to?

Remember, doctors prescribe this medicine after assessing that its benefits are higher than the potential risks for a particular patient. So, one must reach out to the doctor immediately on worsening of following side effects:

Nose bleeding
Eye bruising
Black or Bloody stools
Dark urine
Breathlessness
Nausea, vomiting & dizziness
Headache

Seek immediate medical attention on fainting, heartbeat irregularity, speech & vision troubles and confusion. Allergic reactions are rare.

What is Ticagrelor

Uses of Ticagrelor

Side effects of Ticagrelor

References

Disclaimer: The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.

Need Any Medical Help?

Talk to Our Health Care Experts!

Need Any Medical Help?

Have any Questions?

Frequently Asked Questions about Ticagrelor

No, consumption of such a combination of medicines is not recommended because it may enhance the risk of bleeding.

It works on reducing the stacking capability of platelets. This is because a blood clot forms when there is inter-platelet sticking. It hinders the signalling pathways of certain platelet receptors and subsequently inhibits platelet activation. It has faster and more potent action than clopidogrel on platelet aggregation inhibition.

After ST-elevated myocardial infarction or in coronary artery disease patients, doctors recommend Ticagrelor for consumption initially, followed by substituting it with clopidogrel. Twelve hours after the last consumption of Ticagrelor, a loading dosage of 300 mg clopidogrel is advised for the medicine switching. Then continue with 75 mg clopidogrel for maintenance therapy.

Undoubtedly, it is a blood thinner. Doctors usually prescribe it to lower the risk of a heart attack. The abnormal formation of blood clots may trigger such an event. This medicine helps in thinning of blood to maintain optimum and smooth blood flow. Moreover, it is also prescribed to manage certain post-surgical complications like abnormal blood clotting.

Yes. This medicine is an anticoagulant, as it has a huge therapeutic capability to inhibit abnormal platelet aggregation from forming unwanted blood clots.

One needs to seize the consumption of this antiplatelet medicine at least 5 days before any surgery. This is because this medicine inhibits platelet aggregation even for the normal coagulation process. If coagulation does not occur during and after the surgery, it will result in excessive blood loss and failed post-surgical healing.

The main cause behind such drug-induced dyspnea is that its usage inhibits sodium-independent Equilibrative Nucleoside transporter-1. This results in excess adenosine levels in the blood. High adenosine levels in the blood become the reason behind associated dyspnea.

Low dose aspirin with Ticagrelor is the standard regime to induce inhibition of platelet aggregation in patients with acute coronary artery syndrome. This drug combination reduces the risks of occurrence of major adverse cardiovascular events for long in high-risk patients. Alone, aspirin administration is unable to lower these risks much.

It is from the category of antiplatelet drugs.

As per the Controlled Substance Act, it is not a controlled substance.

The mean half-life of this medication is 7 hours. The active metabolite stays for 9 hours in your body.